FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC: Form 990, tax year 2015
View the entire original 990 at ProPublica ↗
- Organization
- FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC (EIN 52-1986675)
- Tax period
- 2015-01-01 to 2015-12-31
- Filed
- 2016-11-14
- IRS object ID
- 201643199349308279
- Schema version
- 2015v2.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2016-11-14T14:52:00-06:00 | ReturnTs |
| Tax Period End | 2015-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 560747981 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DIXON HUGHES GOODMAN LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 901 EAST CARY STREET SUITE 1000 | AddressLine1Txt |
| City | RICHMOND | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 23219 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2015-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 521986675 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FOUNDATION FOR THE NATIONAL INSTITUTES | BusinessNameLine1Txt |
| Business Name Line2 | OF HEALTH INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | FOUN | BusinessNameControlTxt |
| Phone | 3014025311 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE NO 3411 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MARIA FREIRE PHD | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 3014025311 | PhoneNum |
| Signature | 2016-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | LORI K COCHRAN | PreparerPersonNm |
| PTIN | P00853221 | PTIN |
| Phone | 8042827636 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2015 | TaxYr |
| Build TS | 2017-02-10 21:41:12Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | MARIA FREIRE PHD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE NO 3411 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $101,898,167 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | HTTP://WWW.FNIH.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2001 | FormationYr |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Activity Or Mission | THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 27 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 26 | VotingMembersIndependentCnt |
| Total Employee | 52 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $73,905,546 | PYContributionsGrantsAmt |
| CY Contributions Grants | $33,961,606 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $197,177 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $194,500 | CYProgramServiceRevenueAmt |
| PY Investment Income | $148,518 | PYInvestmentIncomeAmt |
| CY Investment Income | $385,451 | CYInvestmentIncomeAmt |
| PY Other Revenue | $199,253 | PYOtherRevenueAmt |
| CY Other Revenue | $24,552 | CYOtherRevenueAmt |
| PY Total Revenue | $74,450,494 | PYTotalRevenueAmt |
| CY Total Revenue | $34,566,109 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $57,340,984 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $43,310,618 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $5,868,172 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $6,530,244 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $184,983 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $10,868,336 | PYOtherExpensesAmt |
| CY Other Expenses | $9,228,745 | CYOtherExpensesAmt |
| PY Total Expenses | $74,077,492 | PYTotalExpensesAmt |
| CY Total Expenses | $59,069,607 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $373,002 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$24,503,498 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $99,015,541 | TotalAssetsBOYAmt |
| Total Assets EOY | $74,645,303 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $7,446,160 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $8,169,755 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $91,569,381 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $66,475,548 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O, STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENTTHE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $53,079,319 | ExpenseAmt |
| Grant | $42,319,869 | GrantAmt |
| Revenue | $194,500 | RevenueAmt |
| Desc | SEE SCHEDULE O, PROGRAM ONE, RESEARCH PARTNERSHIPSPROGRAM ONE - RESEARCH PARTNERSHIPS - SINCE ITS ESTABLISHMENT NEARLY TWO DECADES AGO, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH (FNIH) HAS BECOME A LEADER IN FORGING POWERFUL PUBLIC-PRIVATE PARTNERSHIPS THAT ADVANCE BIOMEDICAL SCIENCE. WITH THE CAREFUL CRAFTING AND EXECUTION OF CUTTING-EDGE INITIATIVES, THE FNIH HELPS THE NATIONAL INSTITUTES OF HEALTH (NIH) TURN DISCOVERY INTO IMPROVED HEALTH. HIGHLIGHTS FROM FNIH'S 2015 PROGRAMMATIC PORTFOLIO ARE REFERENCED BELOW.FINDING BETTER MARKERS OF OSTEOARTHRITIS ONSET AND PROGRESSION OSTEOARTHRITIS DEVELOPS OVER TIME AS A JOINT'S "CUSHION" OF CARTILAGE BREAKS DOWN AND BONE ENDS RUB TOGETHER, CAUSING PAIN AND LOSS OF FUNCTION. KNEE OSTEOARTHRITIS (OA) IS THE LEADING CAUSE OF DISABILITY IN OLDER ADULTS AND AFFECTS ABOUT 250 MILLION PEOPLE WORLDWIDE. RIGHT NOW, OA IS DIAGNOSED ONLY AFTER PEOPLE HAVE DISCOMFORT, AND THE STANDARD TOOL IS AN X-RAY SHOWING JOINT SPACE NARROWING. BUT THE DISEASE PROCESS BEGINS LONG BEFORE SYMPTOMS APPEAR; IDENTIFYING THOSE AT RISK AND INTERVENING EARLIER COULD HELP AVOID COSTLY JOINT REPLACEMENTS. EARLIER DIAGNOSIS MAY SOON BE POSSIBLE THANKS TO THE OSTEOARTHRITIS BIOMARKERS PROJECT, A $3.4 MILLION STUDY LED BY THE FNIH BIOMARKERS CONSORTIUM IN PARTNERSHIP WITH THE NATIONAL INSTITUTE OF MUSCULOSKELETAL AND SKIN DISEASES, THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), UNIVERSITIES AND PHARMACEUTICAL COMPANIES TO IDENTIFY BIOMARKERS (BIOLOGICAL MARKERS) OF KNEE OA ONSET AND PROGRESSION. USING DATA FROM 5,000 HIGH-RISK PATIENTS GATHERED THROUGH THE NATIONAL INSTITUTES OF HEALTH OSTEOARTHRITIS INITIATIVE, ANOTHER PUBLIC-PRIVATE PARTNERSHIP THAT CREATED AN OPEN-ACCESS REPOSITORY OF MEDICAL IMAGES AND BLOOD AND URINE SAMPLES, THE FNIH-LED TEAM HAS NARROWED THOUSANDS OF POTENTIAL BIOMARKERS DOWN TO A SUBSET THAT CORRELATES WITH KNEE OA PROGRESSION. THESE INCLUDE BONE AND CARTILAGE CHANGES VISIBLE ON MRI AND PROTEINS DETECTABLE IN BLOOD AND URINE. THE BIOMARKERS CAN PAVE THE WAY TOWARD IDENTIFYING PEOPLE AT RISK AND DEVELOPING TREATMENTS THAT TARGET THE DISEASE PROCESS.IDENTIFYING NEW TARGETS TO DRIVE DRUG DEVELOPMENT LAUNCHED IN 2014, THE ACCELERATING MEDICINES PARTNERSHIP (AMP) IS A FIVE-YEAR, $230 MILLION EFFORT JOINING THE RESOURCES OF THE FNIH, THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE FDA WITH THOSE OF SEVERAL NONPROFIT ORGANIZATIONS AND BIOPHARMACEUTICAL COMPANIES TO DEVISE A MORE PRECISE APPROACH TO EARLY-STAGE DRUG DEVELOPMENT. THESE ORGANIZATIONS ARE SHARING EXPERTISE AND DATA TO IDENTIFY THE BIOLOGICAL PATHWAYS UNDERLYING FOUR DEVASTATING DISEASES-TYPE 2 DIABETES (T2D), RHEUMATOID ARTHRITIS/SYSTEMIC LUPUS ERYTHMATOSUS (RA/SLE) AND ALZHEIMER'S DISEASE (AD)-AND THEN VALIDATE THE BEST CANDIDATES FOR TARGETING NEW MEDICINES. AMP'S VISION IS TO EMPOWER RESEARCHERS TO PURSUE NEW TREATMENTS WITH BETTER ODDS OF MOVING THROUGH THE CLINICAL TRIALS PIPELINE SUCCESSFULLY. CURRENT THERAPIES FOR THESE CONDITIONS CANNOT REVERSE THE DISEASE PROCESS NOR STOP ITS PROGRESSION. IN 2015, THE AMP-T2D PROJECT PUBLICLY LAUNCHED A KNOWLEDGE PORTAL THAT HAS AMASSED LARGE AMOUNTS OF GENETIC AND CLINICAL DATA FROM AN ARRAY OF STUDIES ON PEOPLE WITH TYPE 2 DIABETES. THE PORTAL'S DATA COVER A WIDE VARIETY OF ETHNICITIES, INCLUDING AFRICAN-AMERICAN, EAST ASIAN, SOUTH ASIAN, EUROPEAN AND HISPANIC, AS WELL AS DIABETES-RELATED CARDIOVASCULAR AND KIDNEY COMPLICATIONS. RESEARCHERS WILL BE ABLE TO SEARCH AND ANALYZE THE DATA TO IDENTIFY GENETIC VARIANTS ASSOCIATED WITH INCREASED RISK FOR, OR PROTECTION AGAINST, THE DEVELOPMENT OF DIABETES AND ITS COMPLICATIONS. IN TURN, THESE CAN BECOME POTENTIAL TARGETS FOR NEW TREATMENTS. THE AMP-RA/SLE PROJECT HAS DEVELOPED NEW METHODS FOR ACQUIRING AND PROCESSING TISSUE FROM THE KIDNEYS AND SYNOVIAL MEMBRANES (LININGS OF JOINTS) AND TRAINED RESEARCHERS TO USE THESE METHODS, MAKING MULTI-SITE CLINICAL STUDIES POSSIBLE. THIS TISSUE, ALONG WITH BLOOD AND URINE SAMPLES, IS BEING UTILIZED TO GENERATE A NEW PUBLIC DATA REPOSITORY TO BE LAUNCHED IN 2016. FOR THE FIRST TIME, PARTNER ORGANIZATIONS WILL BE ABLE TO COLLABORATE ON GENOME-WIDE ANALYSIS OF THESE SAMPLES TO BETTER UNDERSTAND THE MECHANISMS BEHIND THE DESTRUCTION CAUSED BY RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHMATOSUS, BOTH DISEASES IN WHICH THE BODY'S IMMUNE SYSTEM DESTROYS HEALTHY TISSUE. AMP-AD INCLUDES TWO DIFFERENT PROJECTS. PROJECT A SEEKS TO VALIDATE EXISTING BIOMARKERS AS POSSIBLE INDICATORS OF RESPONSE TO TREATMENT IN PEOPLE WITH ALZHEIMER'S DISEASE. JUST ONE EXAMPLE IS PET IMAGING OF TAU PROTEINS IN THE BRAIN, WHICH HAS BEEN ADDED TO TWO MAJOR NIH-FUNDED PHASE II/III DRUG TRIALS. PROJECT B IS WORKING TO ACCELERATE THE DISCOVERY OF NEW THERAPEUTIC TARGETS, MOVING BEYOND THE TRADITIONAL FOCUS ON THE BUILDUP OF PROTEINS SUCH AS AMYLOID AND TAU IN BRAIN TISSUE. RESEARCHERS BUILD A DEEPER UNDERSTANDING OF THE NETWORKS IN WHICH THESE NOVEL TARGETS OPERATE AND VALIDATE THEM IN DIFFERENT MODELS. THE PROJECT INTEGRATES ANALYSIS OF LARGE-SCALE MOLECULAR DATA FROM MORE THAN 2,000 HUMAN BRAINS AT ALL STAGES OF THE DISEASE WITH NETWORK MODELING APPROACHES AND EXPERIMENTAL VALIDATION. THIS PROJECT HAS CREATED A KNOWLEDGE PORTAL THAT ENABLES RAPID, BROAD SHARING OF DATA AND ANALYTICAL TOOLS, AND PERIODICALLY RELEASES PUBLIC WAVES OF LARGE-SCALE MOLECULAR DATA FROM HUMAN BRAIN SAMPLES. THE ULTIMATE GOAL IS TO SHORTEN THE TIME BETWEEN DISCOVERY OF POTENTIAL DRUG TARGETS TO DEVELOPMENT OF NEW DRUGS FOR ALZHEIMER'S TREATMENT AND PREVENTION.IDENTIFYING BIOMARKERS IN CHILDREN TO HELP ADVANCE AUTISM RESEARCH AN AVERAGE OF ONE IN EVERY 68 EIGHT-YEAR-OLD CHILDREN IN THE UNITED STATES IS DIAGNOSED WITH AUTISM SPECTRUM DISORDER (ASD), TYPICALLY BASED ON BEHAVIORAL OBSERVATIONS BY PARENTS AND CAREGIVERS-BUT THESE BEHAVIORS CAN RANGE WIDELY. DEVELOPING EFFECTIVE INTERVENTIONS AND TREATMENTS THROUGH CLINICAL TRIALS DEPENDS ON DEVELOPING MORE SENSITIVE AND OBJECTIVE STANDARDS FOR DIAGNOSING ASD IN CHILDREN AND EVALUATING CHANGE OVER TIME. IN 2015, THE FNIH PARTNERED WITH THE NATIONAL INSTITUTE OF MENTAL HEALTH, SIMONS FOUNDATION AUTISM RESEARCH INITIATIVE (SFARI), FDA, JANSSEN RESEARCH & DEVELOPMENT, LLC AND EUROPEAN AUTISM INTERVENTIONS - A MULTICENTRE STUDY FOR DEVELOPING NEW MEDICATIONS (EU-AIMS) TO SUPPORT A STUDY OF PRESCHOOL AND SCHOOL-AGED CHILDREN WITH ASD TO VALIDATE BIOMARKERS THAT COULD HELP ASSESS SOCIAL FUNCTION, TRACK CHANGES IN BEHAVIOR AND NEUROLOGIC FUNCTION, AND POTENTIALLY EVALUATE THE EFFECTIVENESS OF PHARMACOLOGIC TREATMENTS. THE FNIH IS MANAGING A $2 MILLION CONTRIBUTION FROM SFARI TO FUND THE YALE UNIVERSITY STUDY LED BY JAMES MCPARTLAND, PH.D., PRINCIPAL INVESTIGATOR, WHICH IS COLLECTING DATA FROM CHILDREN AT FIVE SITES NATIONWIDE USING ASSESSMENTS OF SOCIAL IMPAIRMENT, SUCH AS CLINICIAN, CAREGIVER AND LAB-BASED TOOLS; NEUROPHYSIOLOGICAL MEASURES, SUCH AS EYE TRACKING AND STUDIES OF BRAIN ACTIVITY (EEG, OR ELECTROENCEPHALOGRAM); AND BLOOD SAMPLES FROM PARTICIPANTS AND THEIR PARENTS FOR GENETIC ANALYSIS. THIS $28 MILLION LARGE-SCALE U.S. PARTNERSHIP TO IDENTIFY BIOMARKERS ASSOCIATED WITH ASD IS PART OF THE FNIH BIOMARKERS CONSORTIUM.BUILDING RESEARCH INFRASTRUCTURE IN AFRICATO DEVELOP THE NEW VACCINES AND TREATMENTS THAT IMPROVE PUBLIC HEALTH, RESEARCHERS REQUIRE ACCESS TO HIGH-PERFORMANCE COMPUTING RESOURCES FOR COLLECTING AND ANALYZING COMPLEX BIOLOGICAL DATA. MANY LOW-INCOME COUNTRIES LACK THE INFRASTRUCTURE NEEDED FOR BIOINFORMATICS RESEARCH, EVEN AS THEY FACE SOME OF THE WORLD'S MOST CHALLENGING AND OFTEN-NEGLECTED DISEASES. LAST YEAR, THE FNIH PLAYED A PIVOTAL ROLE IN HELPING THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) LAUNCH THE FIRST AFRICAN CENTER OF EXCELLENCE IN BIOINFORMATICS (ACE) IN MALI, WEST AFRICA. BUILDING ON NIAID'S ONGOING SUPPORT FOR RESEARCHERS IN MALI, THE FNIH INVITED CORPORATE PARTNERS SUCH AS THE BIOTEAM INC., INTEL CORPORATION HEALTH AND LIFE SCIENCES GROUP, THE EMC CORPORATION AND HEWLETT PACKARD ENTERPRISE TO DONATE EQUIPMENT FOR COMPUTING AND DATA ANALYSIS, HIGH-SPEED CONNECTIVITY, AND RESEARCH AND CLASSROOM SPACES. MALI ACE OPENED IN APRIL 2015 AT THE UNIVERSITY OF SCIENCES, TECHNIQUES AND TECHNOLOGY OF BAMAKO (USTTB). LOCAL RESEARCHERS ARE NOW ABLE TO CONDUCT ADVANCED BIOINFORMATICS RESEARCH WHILE RECEIVING LONG-DISTANCE TRAINING AND MENTORSHIP BY NIAID RESEARCHERS. MALI ACE WILL SERVE AS A MODEL FOR FUTURE BIOINFORMATICS RESEARCH CENTERS IN OTHER REGIONS OF AFRICA.CONTINUING IN THE SEARCH FOR AN HIV VACCINE SINCE THE MID-1990S, THE SUCCESSFUL DEVELOPMENT OF MEDICATIONS FOR PEOPLE WITH HUMAN IMMUNODEFICIENCY VIRUS, OR HIV, HAS DEFLECTED SOME ATTENTION FROM THE SEARCH FOR A PREVENTIVE VACCINE. BUT NO MEDICINE HAS CURED HIV, AND ONLY ABOUT HALF OF THE MORE THAN 33 MILLION HIV-POSITIVE PEOPLE WORLDWIDE CAN ACCESS TREATMENT. A SUCCESSFUL VACCINE IS STILL CONSIDERED FUNDAMENTAL FOR CONQUERING HIV/AIDS. FOR NEARLY 10 YEARS, THE FNIH HAS SERVED AS COORDINATOR FOR THE COMPREHENSIVE T CEL | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,210,274 | ExpenseAmt |
| Grant | $891,762 | GrantAmt |
| Desc | SEE SCHEDULE O, PROGRAM TWO, FELLOWSHIPS AND TRAINING PROGRAMSPROGRAM TWO - FELLOWSHIPS AND TRAINING PROGRAMS - RECOGNIZING GROUNDBREAKING WORK BY EARLY-CAREER SCIENTISTS DUE TO STEADY DECLINES IN FINANCIAL SUPPORT FOR BASIC SCIENCE RESEARCH, TODAY'S YOUNG SCIENTISTS FACE A CHALLENGING ENVIRONMENT IN WHICH TENURE-TRACK UNIVERSITY POSITIONS ARE SCARCE AND ABOUT 85 PERCENT OF RESEARCH GRANT PROPOSALS ARE UNFUNDED. IT IS NOT UNUSUAL FOR BIOMEDICAL RESEARCHERS TO REACH THEIR LATE 30S OR 40S BEFORE RECEIVING A MAJOR RESEARCH GRANT-AND THIS AFFECTS THEIR ABILITY TO MAKE SIGNIFICANT, CAREER-CHANGING DISCOVERIES. THREE YEARS AGO, THE FNIH ESTABLISHED THE LURIE PRIZE IN BIOMEDICAL SCIENCES, NAMED FOR PHILANTHROPIST AND BOARD MEMBER ANN LURIE, TO HELP PROPEL THE WORK OF ONE TRULY STELLAR, EARLY-CAREER RESEARCHER EACH YEAR. THE PRESTIGIOUS PRIZE, WHICH INCLUDES A MEDAL AND SIGNIFICANT RESEARCH HONORARIUM, IS AWARDED AT A WASHINGTON, DC CEREMONY EVERY SPRING. THE 2015 LURIE PRIZE WINNER WAS HOWARD HUGHES MEDICAL INSTITUTE INVESTIGATOR AND STANFORD UNIVERSITY NEUROSCIENTIST AND PSYCHIATRIST KARL DEISSEROTH, M.D., PH.D., WHO ALONG WITH HIS TEAM HAS PIONEERED TWO GAME-CHANGING TECHNIQUES: OPTOGENETICS, WHICH USES LIGHT TO MAP THE NEURAL CIRCUITS IN OUR BRAINS, AND A TECHNOLOGY CALLED CLARITY THAT ALLOWS SCIENTISTS TO MAKE ORGANS TRANSPARENT AND THEREFORE EASIER TO STUDY UNDER A MICROSCOPE. IN HIS HANDS, BOTH PROMISE TO REVOLUTIONIZE OUR APPROACH TO NEUROLOGICAL DISEASES SUCH AS MAJOR DEPRESSION, ALZHEIMER'S AND PARKINSON'S.PREVENTING COGNITIVE DECLINE AGE-RELATED DECLINE IN COGNITIVE FUNCTION IS REAL AND VARIES WIDELY AMONG INDIVIDUALS, INFLUENCING QUALITY OF LIFE, CHARACTER OF PERSONAL RELATIONSHIPS AND CAPACITY FOR MAKING INFORMED DECISIONS ABOUT HEALTH CARE, RETIREMENT AND OTHER ISSUES FACED DAILY BY MILLIONS OF OLDER ADULTS. IN 2007, THE MCKNIGHT BRAIN RESEARCH FOUNDATION (MBRF) PARTNERED WITH THE FNIH AND THE NATIONAL INSTITUTE ON AGING (NIA) TO FUND THE FIRST COGNITIVE AGING SUMMIT, WHERE DOZENS OF RESEARCHERS SHARED IDEAS ABOUT HOW BEST TO UNDERSTAND AND REMEDIATE AGE-RELATED COGNITIVE DECLINE. THE SUMMIT LED TO THE RESEARCH PARTNERSHIP IN COGNITIVE AGING IN 2008, A PUBLIC-PRIVATE EFFORT BETWEEN THE NIA AND THE MBRF. BEGINNING IN 2009, THE PARTNERSHIP FUNDED TWO RESEARCH INITIATIVES, 17 GRANTS TOTALING $28 MILLION OVER FIVE YEARS. THE PARTNERSHIP SUPPORTED A SECOND SUMMIT IN 2010, WITH RECOMMENDATIONS LEADING TO A THIRD JOINT INITIATIVE FOCUSED ON INTERVENTIONS. IN 2014, THE PARTNERSHIP, ALONG WITH THE NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH AND THE NIH OFFICE OF BEHAVIORAL AND SOCIAL SCIENCES RESEARCH, FUNDED THE $15 MILLION MEDEX (MINDFULNESS, HEALTH EDUCATION, & EXERCISE) TRIAL. NOW UNDERWAY, THE TRIAL IS COMPARING THE EFFECTIVENESS OF MINDFULNESS-BASED STRESS REDUCTION, BRAIN HEALTH EDUCATION AND AEROBIC EXERCISE AS STRATEGIES FOR IMPROVING COGNITIVE FUNCTION.EDMOND J. SAFRA FAMILY LODGE: 10 YEARS OF CARING ON NOVEMBER 5, 2015, THE FNIH WELCOMED BOARD MEMBER AND GUEST OF HONOR MRS. LILY SAFRA TO CELEBRATE THE 10TH ANNIVERSARY OF THE EDMOND J. SAFRA FAMILY LODGE, WHICH SINCE 2005 HAS HOSTED MORE THAN 100,000 ROOM NIGHTS FOR PATIENTS OF THE NIH CLINICAL CENTER AND THEIR FAMILIES. THE FAMILY LODGE PROVIDES A HOME-LIKE SETTING FREE OF CHARGE FOR GUESTS FROM ACROSS THE NATION AND AROUND THE WORLD. THIS SERVICE EXISTS THANKS TO THE GENEROSITY OF THE EDMOND J. SAFRA PHILANTHROPIC FOUNDATION AND MANY OTHER INDIVIDUAL DONORS, CORPORATIONS AND FOUNDATIONS. MRS. LILY SAFRA DONATED PROCEEDS FROM HER JEWELS FOR HOPE AUCTION TO SUPPORT THE PRESERVATION OF THE FAMILY LODGE ACCORDING TO HER VISION.MEDICATION DONATIONS HELP REDIRECT FUNDS TO RESEARCH SINCE 2009, SANOFI FOUNDATION FOR NORTH AMERICA AND NOVARTIS PHARMACEUTICALS CORPORATION HAVE DONATED MORE THAN $6.4 MILLION IN MEDICATIONS TO THE NIH CLINICAL CENTER THROUGH THE FNIH'S IN-KIND DRUG DONATION PROGRAM, FREEING UP CRITICAL DOLLARS FOR RESEARCH. THE CENTER IS THE NATION'S LARGEST HOSPITAL ENTIRELY DEVOTED TO CLINICAL RESEARCH, AND PATIENTS RECEIVE ALL CARE FREE OF CHARGE.MORE FELLOWSHIPS FOR KIDNEY CANCER RESEARCH OCTOBER 4, 2015, MARKED THE 10TH ANNIVERSARY OF THE BOO! RUN FOR LIFE EVENT IN WASHINGTON, DC TO BENEFIT THE DEAN R. O'NEILL RENAL CELL CANCER FUND. THIS FUND, TOGETHER WITH THE DR. EDWARD T. RANCIC MEMORIAL CANCER RESEARCH FUND, SUPPORTS A ROTATION OF FULL-TIME FELLOWS IN THE LABORATORY OF DR. RICHARD CHILDS OF THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE, WHERE THEY FOCUS ON DEVELOPING NOVEL THERAPIES FOR ADVANCED KIDNEY CANCER. SUPPORT FOR A NEW GENERATION OF RESEARCH SCIENTISTS IN FALL 2015, TWO YOUNG SCHOLARS AT THE NIH WERE AWARDED FULL FUNDING FOR THEIR FIRST YEAR OF EDUCATION AND TRAINING, THANKS TO A GENEROUS GIFT TO THE FNIH BY THE JAYNE KOSKINAS TED GIOVANIS (JKTG) FOUNDATION FOR HEALTH AND POLICY. JOSE DELGADO-JIMENEZ RECEIVED AN NIH POSTBACCALAUREATE INTRAMURAL RESEARCH TRAINING AWARD/CANCER RESEARCH TRAINING AWARD (POSTBAC IRTA/CRTA), WHICH OFFERS RECENT COLLEGE GRADUATES WHO PLAN TO APPLY TO GRADUATE OR HEALTH PROFESSIONAL SCHOOL THE OPPORTUNITY TO SPEND ONE OR TWO YEARS PERFORMING FULL-TIME RESEARCH AT THE NIH. JOSE HAS A SPECIAL INTEREST IN NANOTECHNOLOGY AND CANCER THERAPEUTICS. THE JKTG FOUNDATION GIFT ALSO SUPPORTED A SCHOLARSHIP TO NIH'S GRADUATE PARTNERSHIP PROGRAM (GPP), WHICH BRINGS PH.D. STUDENTS TO THE NIH INTRAMURAL RESEARCH PROGRAM FOR DISSERTATION RESEARCH. AWARDEE RYAN PHILLIPS' RESEARCH INTERESTS INCLUDE MATHEMATICAL/ MOLECULAR MODELING AND BRAIN CIRCUITRY. BOTH STUDENTS ARE WORKING SIDE-BY-SIDE WITH SOME OF THE LEADING SCIENTISTS IN THE WORLD AND EXPERIENCING THE COLLABORATIVE, INTERDISCIPLINARY RESEARCH ENVIRONMENT THAT NIH HAS TO OFFER.NEW FUNDING, NEW CAREER PATHWAYSTWO MAJOR GRANTS THROUGH THE FNIH ARE HELPING THE NIH CREATE NEW CAREER-BUILDING OPPORTUNITIES FOR ASPIRING RESEARCHERS. THANKS TO AN $850,000 GRANT FROM THE AMGEN FOUNDATION, THE NIH IS NOW ONE OF A SELECT GROUP OF HIGHER LEARNING INSTITUTIONS TAKING PART IN THE AMGEN SCHOLARS PROGRAM, WHICH PROVIDES HUNDREDS OF SUMMER RESEARCH OPPORTUNITIES TO UNDERGRADUATE STUDENTS. A $200,000 GIFT FROM THE CONGRESS OF NEUROLOGICAL SURGEONS (CNS) HAS CREATED THE NINDS/CNS GETCH SCHOLAR AWARD IN COLLABORATION WITH THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS). THIS COMPETITIVE AWARD WILL PROVIDE TWO YEARS OF FUNDING TO HELP AN EARLY-CAREER NEUROSURGEON LAUNCH A CLINICAL AND RESEARCH CAREERLAUNCHING WOMEN INTO RESEARCH CAREERS IN 2015, THE SALLIE ROSEN KAPLAN POSTDOCTORAL FELLOWSHIP FOR WOMEN SCIENTISTS IN CANCER RESEARCH (SRK) PROGRAM WELCOMED 10 OUTSTANDING POST-DOCTORAL NATIONAL CANCER INSTITUTE RESEARCHERS-ALL FEMALE AND SOME FROM UNDERREPRESENTED MINORITY GROUPS-TO PARTICIPATE IN LEADERSHIP WORKSHOPS AND SEMINARS, RECEIVE MENTORING AND COACHING AND DEVELOP A PEER NETWORK. THE PROGRAM IS DESIGNED TO HELP WITH THEIR TRANSITION TO INDEPENDENT RESEARCH CAREERS.HUMAN GENOME EXHIBIT ON TOUR THREE MILLION SMITHSONIAN VISITORS TOURED GENOME: UNLOCKING LIFE'S CODE FROM JUNE 2013 TO AUGUST 2014 AT THE NATIONAL MUSEUM OF NATURAL HISTORY, AN EXHIBITION MADE POSSIBLE THROUGH FUNDS RAISED, IN PART, BY THE FNIH. THE RESULT OF A COLLABORATION BETWEEN THE MUSEUM AND THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE, GENOME SHOWCASED THE COMPLEXITY AND POWER OF THE HUMAN GENOME USING 3-D MODELS, INTERACTIVE DISPLAYS, CUSTOM ANIMATIONS AND REAL-LIFE STORIES. THE EXHIBIT IS NOW ON A FIVE-YEAR TOUR TO MUSEUMS AND SCIENCE CENTERS ACROSS NORTH AMERICA.- 2015 HOST CITIES: PORTLAND, SAINT LOUIS, SAN DIEGO AND SAN JOSE - 2016 HOST CITIES: MILWAUKEE (JAN. 23-APRIL 25), SALT LAKE CITY (MAY 21-SEPT. 5) AND WICHITA (SEPT. 30 - JAN. 1, 2017) | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $734,853 | ExpenseAmt |
| Grant | $88,504 | GrantAmt |
| Desc | SEE SCHEDULE O, PROGRAM THREE, MEMORIALS, AWARDS AND EVENTSPROGRAM THREE - MEMORIALS, AWARDS AND EVENTS - COLLABORATION HAPPENS WHEN PEOPLE CONNECT. THAT IS WHY MANAGING AND ORGANIZING MEETINGS AND EVENTS IS FUNDAMENTAL TO THE WORK OF THE FNIH. FROM LECTURES AND WORKSHOPS TO COLLABORATIVE SUMMITS, TELECONFERENCES AND MEDIA OPPORTUNITIES, THE FNIH FACILITATED MORE THAN 50 EVENTS IN 2015 - SPANNING THE GLOBE AND DOZENS OF FIELDS OF RESEARCH. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $313,270 | ExpenseAmt |
| Grant | $10,484 | GrantAmt |
| Desc | PROGRAM FOUR - CAPITAL PROJECTS - THE FOUNDATION'S CAPITAL PROJECTS ENHANCE THE RESEARCH ENVIRONMENT AT NIH, SUPPORTING AND PROMOTING THE IMPORTANT DISCOVERIES THAT RESULT FROM NIH'S LEADING-EDGE WORK. THE EDMOND J. SAFRA FAMILY LODGE, FOR EXAMPLE, OPENED IN 2005 TO SERVE AS A COMFORTABLE HOME-AWAY-FROM-HOME FOR FAMILIES THAT COME TO NIH'S CAMPUS IN BETHESDA, MARYLAND TO ACCOMPANY PATIENTS WHO ARE PARTICIPATING IN CLINICAL TRIALS OR RECEIVING TREATMENT AT NIH'S CLINICAL CENTER. SO FAR, THE LODGE HAS HOSTED MORE THAN 40,000 FAMILY MEMBERS AND CAREGIVERS OF ADULT PATIENTS FROM ALL OVER THE WORLD. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $313,270 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $10,484 | TotalOtherProgSrvcGrantAmt |
| Total Program Service Expenses | $55,337,716 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | Yes (1) | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | Yes (1) | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (1) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 28 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 52 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 27 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 26 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JULIE TUNE | PersonNm |
| Phone | 3014025311 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9650 ROCKVILLE PIKE | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (38 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| DR CHARLES A SANDERS | ||||||||
| CHAIRMAN | 1.50 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| STEVEN C MAYER | ||||||||
| TREASURER | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| THE HON JOHN EDWARD PORTER | ||||||||
| VICE-CHAIRMAN FOR POLICY | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| MRS WILLIAM MCCORMICK BLAIR JR | ||||||||
| SECRETARY | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| DR MARIA C FREIRE | ||||||||
| PRESIDENT AND EXECUTIVE DIRECTOR | 40.00 | Yes (X) | Yes (X) | $385,293 | $0 | $26,500 | ||
| DR SOLOMON H SNYDER | ||||||||
| VICE-CHAIRMAN FOR SCIENCE | 0.50 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| DR PAUL M MONTRONE | ||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||
| DAME JILLIAN SACKLER | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| LILY SAFRA | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR ELLEN V SIGAL | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR STEVEN M PAUL | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| MRS WILLIAM BUFFY N CAFRITZ | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR SAMUEL O THIER | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR MARTIN J MURPHY JR | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR KATHY BLOOMGARDEN | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR JOSEPH M FECZKO | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| ANN LURIE | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR FREDA C LEWIS-HALL | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| ANNE WOJCICKI | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| NINA K SOLARZ | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| JAMES H DONOVAN | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR PAUL L HERRLING | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR RONALD L KRALL | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR EDISON T LIU | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| DR JUDY LANSING KOVLER | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| JOEL S MARCUS | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| RUSSELL W STEENBERG | ||||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | |||
| STEPHANIE JAMES | ||||||||
| DIRECTOR OF SCIENCE & DIRECTOR, GCGH | 40.00 | $296,788 | $0 | $26,500 | Yes (X) | |||
| DAVID WHOLLEY | ||||||||
| DIRECTOR OF RESEARCH PARTNERSHIPS | 40.00 | $298,288 | $0 | $38,333 | Yes (X) | |||
| ANN ASHBY | ||||||||
| DEPUTY EXECUTIVE DIRECTOR | 40.00 | $154,960 | $0 | $23,424 | Yes (X) | |||
| ANDREA BARUCHIN | ||||||||
| SENIOR ADVISOR TO THE PRESIDENT | 40.00 | $173,670 | $0 | $21,937 | Yes (X) | |||
| JULIE TUNE | ||||||||
| CHIEF FINANCIAL OFFICER | 40.00 | $197,756 | $0 | $31,609 | Yes (X) | |||
| JULIA WOLF-RODDA | ||||||||
| DIRECTOR OF DEVELOPMENT | 40.00 | $196,429 | $0 | $31,476 | Yes (X) | |||
| MICHAEL GOTTLIEB | ||||||||
| ASSOCIATE DIRECTOR OF SCIENCE | 40.00 | $241,098 | $0 | $24,110 | Yes (X) | |||
| KAREN TOUNTAS | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $160,218 | $0 | $27,855 | Yes (X) | |||
| STEVE HOFFMANN | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $146,862 | $0 | $26,519 | Yes (X) | |||
| MELISSA CATHER | ||||||||
| DIRECTOR OF ADVANCEMENT | 40.00 | $143,480 | $0 | $14,348 | Yes (X) | |||
| ROSA CANET AVILES | ||||||||
| SCIENTIFIC PROGRAM MANAGER | 40.00 | $141,265 | $0 | $25,960 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,536,107 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $318,571 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 21 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| BUSINESS TALENT GROUP | |||||
| 406 BLACKWELL STREET SUITE 240A | DURHAM | NC | 27701 | CONSULTING | $808,539 |
| ICON EARLY PHASE SERVICES LLC | |||||
| PO BOX 28939 | NEW YORK | NY | 10087 | CLINICAL TRIAL | $513,095 |
| CCS ASSOCIATES INC | |||||
| PO BOX 9125 | MCLEAN | VA | 22102 | CONSULTING | $350,345 |
| THE UNIVERSITY OF TEXASMD ANDERSON | |||||
| PO BOX 4390 | HOUSTON | TX | 77210 | CLINICAL TRIAL | $328,872 |
| MCKINSEY & COMPANY INC | |||||
| PO BOX 7247-7255 | PHILADELPHIA | PA | 19170 | SERVICES TO CONDUCT STUDY | $300,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 22 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $39,000 | FundraisingAmt |
| Government Grants | $1,000,000 | GovernmentGrantsAmt |
| All Other Contributions | $32,922,606 | AllOtherContributionsAmt |
| Noncash Contributions | $677,982 | NoncashContributionsAmt |
| Total Contributions | $33,961,606 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | ADMINISTRATIVE FEES | Desc |
| Business | 561000 | BusinessCd |
| Total Revenue Column | $194,500 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $194,500 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $194,500 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $367,897 | TotalRevenueColumnAmt |
| Exclusion | $367,897 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $67,156,014 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $67,138,460 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $17,554 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $17,554 | TotalRevenueColumnAmt |
| Exclusion | $17,554 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $218,150 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $39,000 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $193,598 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $24,552 | TotalRevenueColumnAmt |
| Exclusion | $24,552 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $34,566,109 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $194,500 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $410,003 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $29,562,490 | TotalAmt |
| Program Services | $29,562,490 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,550 | TotalAmt |
| Program Services | $10,550 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,737,578 | TotalAmt |
| Program Services | $13,737,578 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,897,600 | TotalAmt |
| Program Services | $742,067 | ProgramServicesAmt |
| Management And General | $1,129,340 | ManagementAndGeneralAmt |
| Fundraising | $26,193 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,290,679 | TotalAmt |
| Program Services | $2,175,259 | ProgramServicesAmt |
| Management And General | $1,016,337 | ManagementAndGeneralAmt |
| Fundraising | $99,083 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $360,718 | TotalAmt |
| Program Services | $196,197 | ProgramServicesAmt |
| Management And General | $148,885 | ManagementAndGeneralAmt |
| Fundraising | $15,636 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $630,127 | TotalAmt |
| Program Services | $386,685 | ProgramServicesAmt |
| Management And General | $233,318 | ManagementAndGeneralAmt |
| Fundraising | $10,124 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $351,120 | TotalAmt |
| Program Services | $171,898 | ProgramServicesAmt |
| Management And General | $179,222 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $175,183 | TotalAmt |
| Program Services | $170,954 | ProgramServicesAmt |
| Management And General | $4,229 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $55,585 | TotalAmt |
| Management And General | $55,585 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $73,418 | TotalAmt |
| Program Services | $19,733 | ProgramServicesAmt |
| Management And General | $53,685 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,756 | TotalAmt |
| Program Services | $14,756 | ProgramServicesAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $32,578 | TotalAmt |
| Program Services | $21,475 | ProgramServicesAmt |
| Management And General | $10,676 | ManagementAndGeneralAmt |
| Fundraising | $427 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $165,537 | TotalAmt |
| Program Services | $76,845 | ProgramServicesAmt |
| Management And General | $75,310 | ManagementAndGeneralAmt |
| Fundraising | $13,382 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $519,802 | TotalAmt |
| Program Services | $247,876 | ProgramServicesAmt |
| Management And General | $271,926 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,434,971 | TotalAmt |
| Program Services | $1,361,729 | ProgramServicesAmt |
| Management And General | $71,596 | ManagementAndGeneralAmt |
| Fundraising | $1,646 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,850 | TotalAmt |
| Management And General | $21,850 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $193,885 | TotalAmt |
| Program Services | $145,139 | ProgramServicesAmt |
| Management And General | $48,746 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| PROGRAM CONTRACTS | $3,940,944 | $3,940,944 | ||
| CONSULTANTS | $2,226,968 | $2,069,695 | $157,273 | |
| PRINTING AND PHOTOCOPYI | $251,809 | $238,461 | $2,473 | $10,875 |
| HONORARIA | $160,900 | $160,900 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | -$39,441 | TotalAmt |
| Program Services | -$113,515 | ProgramServicesAmt |
| Management And General | $66,457 | ManagementAndGeneralAmt |
| Fundraising | $7,617 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $59,069,607 | TotalAmt |
| Program Services | $55,337,716 | ProgramServicesAmt |
| Management And General | $3,546,908 | ManagementAndGeneralAmt |
| Fundraising | $184,983 | FundraisingAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,242,543 | BOYAmt |
| EOY | $21,131,272 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,827,866 | BOYAmt |
| EOY | $10,084,867 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $65,998 | BOYAmt |
| EOY | $84,024 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $680,486 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $630,146 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $54,336 | BOYAmt |
| EOY | $50,340 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $58,789,274 | BOYAmt |
| EOY | $43,250,167 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $35,524 | BOYAmt |
| EOY | $44,633 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $99,015,541 | BOYAmt |
| EOY | $74,645,303 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,338,401 | BOYAmt |
| EOY | $1,460,257 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,605,461 | BOYAmt |
| EOY | $5,975,257 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,338,837 | BOYAmt |
| EOY | $577,271 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $163,461 | BOYAmt |
| EOY | $156,970 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,446,160 | BOYAmt |
| EOY | $8,169,755 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,758,572 | BOYAmt |
| EOY | $11,662,389 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $76,594,675 | BOYAmt |
| EOY | $51,608,294 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,216,134 | BOYAmt |
| EOY | $3,204,865 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $91,569,381 | BOYAmt |
| EOY | $66,475,548 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $99,015,541 | BOYAmt |
| EOY | $74,645,303 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$24,503,498 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$590,335 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $59,765,254 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $58,869,026 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $59,135,001 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $73,905,546 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $33,961,607 | CurrentTaxYearAmt |
| Total | $285,636,434 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $59,765,254 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $58,869,026 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $59,135,001 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $73,905,546 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $33,961,607 | CurrentTaxYearAmt |
| Total | $285,636,434 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $152,448,314 | SubstantialContributorsTotAmt |
| Public Support Total170 | $133,188,120 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $134,140 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $140,900 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $213,728 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $214,303 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $367,897 | CurrentTaxYearAmt |
| Total | $1,070,968 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $286,707,402 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $2,635,799 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.46450 | PublicSupportCY170Pct |
| Public Support PY170 | 0.48930 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Donor Advised Funds Held | 2 | DonorAdvisedFundsHeldCnt |
| Donor Advised Funds Contri | $1,525 | DonorAdvisedFundsContriAmt |
| Donor Advised Funds Grants | $5,600 | DonorAdvisedFundsGrantsAmt |
| Donor Advised Funds Vl EOY | $4,134,027 | DonorAdvisedFundsVlEOYAmt |
| Disclosed Org Leg Ctrl | Yes (1) | DisclosedOrgLegCtrlInd |
| Disclosed For Charitable Prps | Yes (1) | DisclosedForCharitablePrpsInd |
| Agent Trustee Etc | 0 | AgentTrusteeEtcInd |
| Incl Escrow Custodial Acct Liab | Yes (1) | InclEscrowCustodialAcctLiabInd |
| Explanation Provided | Yes (X) | ExplanationProvidedInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $9,616,660 | BeginningYearBalanceAmt |
| Contributions | $10,356 | ContributionsAmt |
| Investment Earnings Or Losses | -$100,829 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $24,616 | AdministrativeExpensesAmt |
| End Year Balance | $9,501,571 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,381,374 | BeginningYearBalanceAmt |
| Contributions | $6,271,975 | ContributionsAmt |
| Investment Earnings Or Losses | $11,641 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $48,330 | AdministrativeExpensesAmt |
| End Year Balance | $9,616,660 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,491,739 | BeginningYearBalanceAmt |
| Contributions | $14,559 | ContributionsAmt |
| Investment Earnings Or Losses | -$83,704 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $41,220 | AdministrativeExpensesAmt |
| End Year Balance | $3,381,374 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,498,900 | BeginningYearBalanceAmt |
| Contributions | $15,153 | ContributionsAmt |
| Investment Earnings Or Losses | $25,879 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $48,193 | AdministrativeExpensesAmt |
| End Year Balance | $3,491,739 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,558,830 | BeginningYearBalanceAmt |
| Contributions | $3,214 | ContributionsAmt |
| Investment Earnings Or Losses | -$91 | InvestmentEarningsOrLossesAmt |
| Administrative Expenses | $63,053 | AdministrativeExpensesAmt |
| End Year Balance | $3,498,900 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.65000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.34000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.01000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $680,486 | OtherCostOrOtherBasisAmt |
| Depreciation | $630,146 | DepreciationAmt |
| Book Value | $50,340 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $50,340 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | CHARITABLE GIFT ANNUITY | Desc |
| Amt | $156,970 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $156,970 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $34,505,611 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$590,335 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $336,239 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | -$254,096 | RevenueNotReportedAmt |
| Revenue Subtotal | $34,759,707 | RevenueSubtotalAmt |
| Other Revenues Not Included | -$193,598 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$193,598 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $34,566,109 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $59,599,444 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $336,239 | DonatedServicesUseFcltsAmt |
| Other Expenses Included | $193,598 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $529,837 | ExpensesNotReportedAmt |
| Expenses Subtotal | $59,069,607 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $59,069,607 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART IV, LINE 2B: | AS OF 12/31/2015, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC HELD $577,271 IN AGENCY FUNDS FOR FUTURE DISTRIBUTIONS TO THE NATIONAL INSTITUTES OF HEALTH (NIH). THESE FUNDS ARE DESIGNATED BY THE FUNDER(S) FOR SPECIFIC PROJECTS AT THE NIH, AND WILL BE DISBURSED AS NEEDED. |
| PART V, LINE 4: | THE FOUNDATION'S ENDOWMENTS CONSIST OF INDIVIDUAL DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR A VARIETY OF PURPOSES. (E.G. VARIETY OF RESEARCH AND EDUCATIONAL INITIATIVES AT THE FOUNDATION FOR THE NIH, INC). NET ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OR DONOR-IMPOSED RESTRICTIONS. |
| PART X, LINE 2: | THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF DECEMBER 31, 2015 AND 2014. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | FUNDRAISING DIRECT EXPENSE -193,598. |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | FUNDRAISING DIRECT EXPENSE 193,598. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTMAKING | $3,876,242 |
| EUROPE | 0 | 0 | GRANTMAKING | $9,072,296 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTMAKING | $199,799 |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | $589,241 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continutation Total Office | 0 | ContinutationTotalOfficeCnt |
| Continutation Total Employee | 0 | ContinutationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $13,737,578 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $13,737,578 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (9 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| SOUTH ASIA | MALNUTRITION & ENTERIC DISEASES NETWORK | $313,097 | WIRE TRANSFER |
| SOUTH ASIA | MALNUTRITION & ENTERIC DISEASES NETWORK | $276,144 | WIRE TRANSFER |
| EUROPE | DEVELOP A GENETIC STRATEGY TO DEPLETE OR INCAPACITATE INSECTS/VIMC2 | $7,892,944 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | MODIFYING MOSQUITO POPULATION AGE STRUCTURE TO ELIMINATE DENGUE TRANSMISSION-ELIMINATE DENGUE | $3,866,242 | WIRE TRANSFER |
| EUROPE | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | $489,924 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | BIOMARKERS OSTEOARTHRITIS | $10,000 | WIRE TRANSFER |
| SUB-SAHARAN AFRICA | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | $199,799 | WIRE TRANSFER |
| EUROPE | AMP-T2 DIABETES | $104,365 | WIRE TRANSFER |
| EUROPE | IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS | $585,063 | WIRE TRANSFER |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 9 | Total501c3OrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS SOME DEVELOPING COUNTRY INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. | ExplanationTxt |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | 2015 FNIH AWARD CEREMONY | Event1Nm |
| Gross Receipts Event1 | $247,150 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $39,000 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $208,150 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $30,249 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $155,576 | OtherDirectExpensesEvent1Amt |
| Event2 | 2016 FNIH AWARD CEREMONY | Event2Nm |
| Gross Receipts Event2 | $10,000 | GrossReceiptsEvent2Amt |
| Gross Revenue Event2 | $10,000 | GrossRevenueEvent2Amt |
| Other Direct Expenses Event2 | $7,773 | OtherDirectExpensesEvent2Amt |
| Gross Receipts Total | $257,150 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $39,000 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $218,150 | GrossRevenueTotalEventsAmt |
| Food And Beverage Total Events | $30,249 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $163,349 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $193,598 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | $24,552 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (33 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|
| BETH ISRAEL DEACONESS MEDICAL CENTER | ||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | 501(C)(3) | $221,973 | NON HUMAN PRIMATE NEW ASSAY | |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 1620 TREMONT STREET 3RD FLOOR RM BC | BOSTON | MA | 02120 | 042312909 | 501(C)(3) | $50,836 | EVALUATION OF THE EFFECTS OF FCRN MUTATIONS ON ANTIBODY HALF-LIFE.+ KIDNEY | 3002 |
| CASE WESTERN RESERVE UNIVERSITY | ||||||||
| NORD HALL SUITE 615 10900 EUCLID | CLEVELAND | OH | 44106 | 341018992 | 501(C)(3) | $587,000 | CTVIMC2-MOLECULAR IMMUNE CORRELATES CORE | AVENUE |
| DONALD DANFORTH PLANT SCIENCE CENTER | ||||||||
| 975 NORTH WARSON ROAD | ST LOUIS | MO | 63132 | 311584621 | 501(C)(3) | $166,572 | REGULATORY DEVELOPMENT FOR HEG-MODIFIED MOSQUITOES | |
| DUKE UNIVERSITY | ||||||||
| 2200 WEST MAIN STREET SUITE 820 | DURHAM | NC | 27705 | 560532129 | 501(C)(3) | $635,888 | PROFICIENCY TESTING CENTRAL/CTVIMC2/BIOMARKERS-CECI | ERWIN SQUARE PLAZA |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | $544,993 | CTVIMC2/INNATE AND MUCOSAL IMMUNITY DISCOVERY TEAM | |
| FRIENDS OF CANCER RESEARCH | ||||||||
| 1800 M STREET NW SUITE 1050 SUTH | WASHINGTON | DC | 20036 | 521983273 | 501(C)(3) | $50,000 | LUNGCANCER PROTOCOL | |
| HENRY JACKSON FOUNDATION (USMHRP) | ||||||||
| 1401 ROCKVILLE PIKE SUITE 600 | ROCKVILLE | MD | 20852 | 521317896 | 501(C)(3) | $238,614 | PROFICIENCY TESTING/MAL-ED | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE | NEW YORK | NY | 10029 | 136171197 | 501(C)(3) | $99,905 | AMP-T2 DIABETES | |
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 615 N WOLFE ST W1100 | BALTIMORE | MD | 21205 | 150595110 | 501(C)(3) | $500,000 | MAL-ED | |
| NIA INC OF GREATER RICHMOND | ||||||||
| 4247 CREIGHTON ROAD | RICHMOND | VA | 23223 | 541736110 | 501(C)(3) | $201,000 | HEART TRUTH-WOMEN TAKE CARE CHARGE | |
| NEW YORK BLOOD CENTER | ||||||||
| 310 EAST 67TH STREET | NEW YORK | NY | 10065 | 131949477 | 501(C)(3) | $68,483 | OVAF | |
| NIH- NINR | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $8,081 | RESEARCH | |
| NIH- CLINICAL CENTER | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $564,762 | RESEARCH | |
| NIHOD | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $199,099 | RESEARCH | |
| NIHFIC | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $794,736 | RESEARCH | |
| NIHNCI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858116 | 170(C)(1) GOVT | $799,544 | RESEARCH | |
| NIHNHLBI | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858117 | 170(C)(1) GOVT | $1,134,327 | RESEARCH | |
| NIHNIA | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $9,024,691 | RESEARCH | |
| NIHNIAID | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $2,723,221 | RESEARCH | |
| NIHNIAMS | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $3,000,000 | RESEARCH | |
| NIHNIMH | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $408,553 | RESEARCH | |
| NIHNIDDK | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $185,854 | RESEARCH | |
| NIHNINDS | ||||||||
| 9000 ROCKVILLE PIKE | BETHESDA | MD | 20892 | 520858115 | 170(C)(1) GOVT | $2,820,368 | RESEARCH | |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||
| 3003 SOUTH STATE STREET 1040 | ANN ARBOR | MI | 48109 | 386006309 | 170(C)(1) GOVT | $750,852 | AMP-T2 DIABETES. DEPOSIT OF METSIM AND FUSION DATA INTO KNOWLEDGE PORTAL | WOLVERINE TOWER |
| THOMAS JEFFERSON UNIVERSITY | ||||||||
| 125 SOUTH 9TH ST 2ND FLOOR SHERIDAN | PHILADELPHIA | PA | 19107 | 231352651 | 501(C)(3) | $195,535 | OVAF | BUILDING |
| THE HOPE HEART INSTITUTE | ||||||||
| 1380 112TH AVENUE NORTHEAST SUITE | BELLEVUE | WA | 98004 | 911138000 | 501(C)(3) | $152,325 | HEART TRUTH GRANT | 200 |
| THE PENNYSLVANIA STATE UNIVERSITY | ||||||||
| 401 RIDER BLDG 227 W BEAVER AVE | STATE COLLEGE | PA | 16801 | 246000376 | 170(C)(1) GOVT | $247,311 | MAL-ED | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||
| MISSION HALL 550 16TH STREET 2ND | SAN FRANCISCO | CA | 94143 | 946036493 | 501(C)(3) | $249,500 | OSTEOARTHRITIS/BONE QUALITY | FLOOR |
| THE UNIVERSITY OF CALIFORNIA (RIVERSIDE) | ||||||||
| 200 UNIVERSITY OFFICE BUILDING | RIVERSIDE | CA | 925210217 | 956006142 | 170(C)(1) GOVT | $200,000 | HEART TRUTH- NAVIGATING PACIFIC HEARTS | RIVERSIDE |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| SOTO STREET BUILDING 2001 SOTO | LOS ANGELES | CA | 900899235 | 911642394 | 501(C)(3) | $1,150,000 | AMP-AD TAU PET IMAGING -ALZHEIMER'S THERAPEUTIC RESEARCH INSTITUTE (USC ATRI) A4 TRIAL | STREET |
| UNIVERSITY OF VIRGINIA | ||||||||
| PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | 546001796 | 170(C)(1) GOVT | $1,395,263 | MAL-ED | |
| WEST VIRGINIA UNIVERSITY RESEARCH | ||||||||
| 886 CHESNUT RIDGE ROAD ROOM 202 | MORGANTOWN | WV | 26506 | 550665758 | 501(C)(3) | $193,204 | HEART TRUTH - LOVE YOUR HEART MOVEMENT | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 33 | Total501c3OrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | AWARDS | GrantTypeTxt |
| Recipient | 8 | RecipientCnt |
| Cash Grant | $10,550 | CashGrantAmt |
| Valuation Method Used | FMV | ValuationMethodUsedDesc |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS FOR-PROFIT INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. FELLOWS SELECTED FOR FOUNDATION FELLOWSHIPS ARE SELECTED THROUGH NATIONWIDE AND INTERNATIONAL COMPETITIONS. THE CLINICAL RESEARCH TRAINING PROGRAM (CRTP) IS OPEN TO ALL THIRD YEAR STUDENTS ENROLLED IN MEDICAL OR DENTAL SCHOOLS. THE WOMEN'S HEALTH FELLOWSHIP PROGRAMS ARE OPEN TO DOCTORAL-LEVEL CANDIDATES WITHIN FIVE YEARS OF RECEIPT OF THE DOCTORAL DEGREE. APPLICATIONS, CONTAINING TRANSCRIPTS AND ESSAYS ON THEIR RESEARCH GOALS ARE SUBMITTED AND REVIEWED BY PANELS OF NIH SCIENTISTS WHO MAKE RECOMMENDATIONS FOR SELECTION. POTENTIAL FELLOWS ARE OFTEN BROUGHT TO THE CAMPUS FOR INTERVIEWS AND FINAL SELECTION. THE FOUNDATION'S FELLOWSHIPS ARE OPEN TO PROFESSIONALS WORKING AT VARIOUS STAGES OF THEIR RESEARCH CAREERS. APPLICANTS TO THE NEUROSCIENCE FELLOWSHIP, FOR EXAMPLE, ARE YOUNG SCIENTISTS WHO WILL BENEFIT FROM EXPERIENCE OF CLINICAL AND BASIC SCIENCE RESEARCH. THE DIRECTOR'S FELLOWSHIP IN COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH SEEKS A MORE EXPERIENCED SCIENTIST WHO IS WELL-POSITIONED TO BECOME A LEADER IN THE FIELD OF COMPLEMENTARY ALTERNATIVE MEDICINE. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DR MARIA C FREIRE | ||||||||||||||
| PRESIDENT AND EXECUTIVE DIRECTOR | $385,293 | $0 | $0 | $0 | $0 | $0 | $26,500 | $0 | $0 | $0 | $411,793 | $0 | $0 | $0 |
| STEPHANIE JAMES | ||||||||||||||
| DIRECTOR OF SCIENCE & DIRECTOR, GCGH | $296,788 | $0 | $0 | $0 | $0 | $0 | $26,500 | $0 | $0 | $0 | $323,288 | $0 | $0 | $0 |
| DAVID WHOLLEY | ||||||||||||||
| DIRECTOR OF RESEARCH PARTNERSHIPS | $290,738 | $0 | $5,000 | $0 | $2,550 | $0 | $26,500 | $0 | $11,833 | $0 | $336,621 | $0 | $0 | $0 |
| ANN ASHBY | ||||||||||||||
| DEPUTY EXECUTIVE DIRECTOR | $154,648 | $0 | $0 | $0 | $312 | $0 | $15,496 | $0 | $7,928 | $0 | $178,384 | $0 | $0 | $0 |
| ANDREA BARUCHIN | ||||||||||||||
| SENIOR ADVISOR TO THE PRESIDENT | $173,670 | $0 | $0 | $0 | $0 | $0 | $17,367 | $0 | $4,570 | $0 | $195,607 | $0 | $0 | $0 |
| JULIE TUNE | ||||||||||||||
| CHIEF FINANCIAL OFFICER | $197,256 | $0 | $0 | $0 | $500 | $0 | $19,776 | $0 | $11,833 | $0 | $229,365 | $0 | $0 | $0 |
| JULIA WOLF-RODDA | ||||||||||||||
| DIRECTOR OF DEVELOPMENT | $191,429 | $0 | $3,000 | $0 | $2,000 | $0 | $19,643 | $0 | $11,833 | $0 | $227,905 | $0 | $0 | $0 |
| MICHAEL GOTTLIEB | ||||||||||||||
| ASSOCIATE DIRECTOR OF SCIENCE | $241,098 | $0 | $0 | $0 | $0 | $0 | $24,110 | $0 | $0 | $0 | $265,208 | $0 | $0 | $0 |
| KAREN TOUNTAS | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $160,218 | $0 | $0 | $0 | $0 | $0 | $16,022 | $0 | $11,833 | $0 | $188,073 | $0 | $0 | $0 |
| STEVE HOFFMANN | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $138,862 | $0 | $8,000 | $0 | $0 | $0 | $14,686 | $0 | $11,833 | $0 | $173,381 | $0 | $0 | $0 |
| MELISSA CATHER | ||||||||||||||
| DIRECTOR OF ADVANCEMENT | $143,480 | $0 | $0 | $0 | $0 | $0 | $14,348 | $0 | $0 | $0 | $157,828 | $0 | $0 | $0 |
| ROSA CANET AVILES | ||||||||||||||
| SCIENTIFIC PROGRAM MANAGER | $138,973 | $0 | $0 | $0 | $2,292 | $0 | $14,127 | $0 | $11,833 | $0 | $167,225 | $0 | $0 | $0 |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 3 | ContributionCnt |
| Noncash Contributions Rpt F990 | $28,893 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | STOCK PRICE | MethodOfDeterminingRevenuesTxt |
Drugs And Medical Supplies DrugsAndMedicalSuppliesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 2 | ContributionCnt |
| Noncash Contributions Rpt F990 | $645,974 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | MARKET PRICE | MethodOfDeterminingRevenuesTxt |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | DONATED GOODS | Desc |
| Contribution | 1 | ContributionCnt |
| Noncash Contributions Rpt F990 | $3,115 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | MARKET PRICE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | DR. FREIRE, PRESIDENT OF THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC. (FNIH), IS A NON-EXECUTIVE MEMBER OF THE BOARD OF DIRECTORS OF ALEXANDRIA REAL ESTATE EQUITIES (ARE). MR. JOEL MARCUS, CEO AND CHAIRMAN OF ARE IS A NON-EXECUTIVE MEMBER OF THE FNIH BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION B, LINE 11 | PRIOR TO THE SUBMISSION OF THE FOUNDATION FOR NIH'S FORM 990 TO THE INTERNAL REVENUE SERVICE, EACH VOTING MEMBER OF THE BOARD OF DIRECTORS SHALL BE PROVIDED WITH A COPY OF THE FINAL FORM 990 AS APPROVED BY THE CHIEF FINANCIAL OFFICER. BOARD DIRECTORS SHALL BE PROVIDED WITH AT LEAST TEN BUSINESS DAYS TO REVIEW THE FORM AND RAISE QUESTIONS, MAKE SUGGESTIONS, AND ADDRESS ANY POTENTIAL PROBLEMS OR CONCERNS WITH THE CHIEF FINANCIAL OFFICER. A SPECIAL MEETING OF THE GOVERNANCE COMMITTEE WILL BE CALLED TO REVIEW THE SUGGESTED CHANGES FROM THE BOARD OF DIRECTORS AND TO APPROVE THE FINAL VERSION OF THE FORM 990 FOR SUBMISSION. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE FOUNDATION REQUIRES DIRECTORS, OFFICERS, VOLUNTEER COMMITTEE MEMBERS, AND STAFF MEMBERS TO DISCLOSE REAL AND APPARENT CONFLICTS OF INTEREST FOR THEMSELVES AND THEIR FAMILY MEMBERS AND TO ANNUALLY SIGN A STATEMENT OF COMPLIANCE. AFTER A CONFLICT OR AN APPARENT CONFLICT OF INTEREST HAS BEEN DISCLOSED, THE BOARD OF DIRECTORS OR THE BOARD COMMITTEE, OR THEIR DESIGNEE, IN THE ABSENCE OF THE INTERESTED PERSON, SHALL DETERMINE IF THE CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST EXISTS AND IS MATERIAL AND WILL DECIDE HOW IT IS TO BE MANAGED OR ELIMINATED. |
| FORM 990, PART VI, SECTION B, LINE 15 | BEGINNING IN 2015, THE NEWLY CREATED COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS WILL REVIEW AND APPROVE THE SALARIES OF THE EXECUTIVE DIRECTOR AND KEY EMPLOYEES ANNUALLY. |
| FORM 990, PART VI, SECTION C, LINE 19 | ALL DOCUMENTS ARE AVAILABLE UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS ARE POSTED TO THE ORGANIZATION'S WEBSITE. |
| FORM 990, PART XII, LINE 2C: | PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. |